Efficacy of Lanadelumab in Hereditary Angioedema Patients Switching From C1 Inhibitor Long-Term Prophylaxis: Interim Results From the HELP Open-Label Extension Study

被引：0
|
作者：
Riedl, Marc A. [1 ]
Anderson, John T. [2 ]
Cicardi, Marco [3 ]
Li, H. Henry [4 ]
Lockey, Richard F. [5 ]
Longhurst, Hilary [6 ,7 ]
Maurer, Marcus [8 ]
Lu, Peng [9 ]
Hao, James [9 ]
Banerji, Aleena [10 ]
机构：
[1] Univ Calif San Diego, La Jolla, CA 92093 USA
[2] Clin Res Ctr Alabama, Birmingham, AL USA
[3] Univ Milan, Dept Biomed & Clin Sci, Luigi Sacco Hosp, ASST Fatebenefratelli Sacco, Milan, Italy
[4] Inst Asthma & Allergy, Chevy Chase, MD USA
[5] Univ S Florida, Morsani Coll Med, Dept Internal Med, Div Allergy & Immunol, Tampa, FL USA
[6] Cambridge Univ Hosp NHS Fdn Trust, Dept Immunol, Addenbrookes Hosp, Cambridge, England
[7] Barts Hlth NHS Trust, Dept Immunol, London, England
[8] Charite Univ Med Berlin, Dept Dermatol & Allergy, Berlin, Germany
[9] Shire, Lexington, MA USA
[10] Harvard Med Sch, Div Rheumatol Allergy & Immunol, Dept Med, Massachusetts Gen Hosp, Boston, MA USA
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2019年 / 143卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
112
引用
收藏
页码：AB38 / AB38
页数：1
相关论文
共 50 条
  • [31] Garadacimab For Hereditary Angioedema Prophylaxis In Adolescents: Efficacy And Safety From The Phase 3 (VANGUARD) Study And Open-Label Extension (Second Interim Analysis)
    Jacobs, Joshua
    Magerl, Markus
    Martinez-Saguer, Inmaculada
    Li, Huamin
    Bernstein, Jonathan
    Hsu, Connie
    Sitz, Karl
    Wieman, Lolis
    Feuer-Senger, Henrike
    Pollen, Maressa
    Reshef, Avner
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2024, 153 (02) : AB6 - AB6
  • [32] Efficacy and safety of long-term prophylaxis with C1 inhibitor (C1INH) concentrate in patients with hereditary Angioedema (HAE)
    Uraw, B.
    Busse, P.
    White, M.
    Jacobs, J.
    Lumry, W.
    Baker, J.
    Hurewitz, D.
    Manning, M.
    Koleilat, M.
    Friedman, R. A.
    Wilkinson, R.
    Cartwright, W. E.
    Tanner, D.
    Kohler, G.
    Gunther, G.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2008, 121 (02) : S272 - S272
  • [33] LONG-TERM LANADELUMAB TREATMENT IMPROVES HEALTH-RELATED QUALITY OF LIFE: HELP OPEN-LABEL EXTENSION STUDY INTERIM FINDINGS
    Lumry, W.
    Maurer, M.
    Magerl, M.
    Jain, G.
    Devercelli, G.
    Regnault, A.
    Meunier, J.
    Riedl, M.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2019, 123 (05) : S29 - S29
  • [34] SUBCUTANEOUS C1-INHIBITOR FOR LONG-TERM PROPHYLAXIS IN HEREDITARY ANGIOEDEMA WITH NORMAL C1 INHIBITOR
    Kalamaha, K.
    Fernandes, H.
    Riedl, M.
    Rodrigues, J.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2018, 121 (05) : S89 - S89
  • [35] Effects of long-term prophylaxis with subcutaneous C1 inhibitor in special patient populations: Findings from the COMPACT open-label extension trial
    Levy, D. S.
    Craig, T.
    Longhurst, H.
    Cicardi, M.
    Chiao, J.
    Feuersenger, H.
    Prusty, S.
    Pragst, I
    ALLERGY, 2019, 74 : 10 - 10
  • [36] Attack-free status during steady state of lanadelumab treatment in patients with -hereditary angioedema: findings from the HELP open-label extension study
    Magerl, M.
    Johnston, D. T.
    Lumry, W. R.
    Bernstein, J. A.
    Nurse, C.
    Yu, M.
    Riedl, M. A.
    ALLERGOLOGIE, 2022, 45 (08) : 606 - 606
  • [37] Garadacimab for hereditary angioedema prophylaxis: Efficacy and safety from a Phase 2 open-label extension trial
    Craig, T. J.
    Reshef, A.
    Lumry, W. R.
    Saguer, I. Martinez
    Jacobs, J. S.
    Yang, W. H.
    Aygoren-Pursun, E.
    Keith, P. K.
    Busse, P.
    Magerl, M.
    Feuersenger, H.
    Bica, M. A.
    Glassman, F.
    Pragst, I.
    Levy, D. S.
    ALLERGOLOGIE, 2023, 46 (08) : 560 - 561
  • [38] Efficacy and Safety of a C1 Esterase Inhibitor Concentrate for Long-Term Prophylaxis in Hereditary Angioedema: Findings from a Large International Registry
    Craig, Timothy J.
    Edelman, Jonathan M.
    Feuersenger, Henrike
    Frank, Michael M.
    Rojavin, Mikhail
    Shapiro, Ralph
    Vegh, Arthur B.
    Wuillemin, Walter A.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2015, 135 (02) : AB193 - AB193
  • [39] EFFICACY AND SAFETY OF RECOMBINANT HUMAN C1 ESTERASE INHIBITOR FOR ACUTE ATTACKS OF HEREDITARY ANGIOEDEMA: AN OPEN-LABEL STUDY
    Li, H.
    Moldovan, D.
    Bernstein, J.
    Reshef, A.
    Porebski, G.
    Stobiecki, M.
    Baker, J.
    Levy, R.
    Hardiman, Y.
    Relan, A.
    Cicardi, M.
    Riedl, M.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2013, 111 (05) : A92 - A93
  • [40] Long-term safety and efficacy of garadacimab for preventing hereditary angioedema attacks: Phase 3 open-label extension study
    Reshef, Avner
    Hsu, Connie
    Katelaris, Constance H.
    Li, Philip H.
    Magerl, Markus
    Yamagami, Keiko
    Guilarte, Mar
    Keith, Paul K.
    Bernstein, Jonathan A.
    Lawo, John-Philip
    Shetty, Harsha
    Pollen, Maressa
    Wieman, Lolis
    Craig, Tim J.
    ALLERGY, 2025, 80 (02) : 545 - 556
12345